Melanie De Almeida
German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases
Missed Labiotech Refresh? Have a Look at Our Recap!
Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust?
Norwegian Biotech Hits €21M in Private Placement for its Immunotherapies
German Biotech Unveils Positive Phase II Results for Alzheimer’s
This UK Biotech Wants to Protect People from Hearing Loss
Austrian Biotech Kicks-off NIH-sponsored Trial of its Chikungunya Vaccine
French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug
This French Biotech Wants to Reinvent DC-based Immunotherapies
German Biotech Enters the Clinic with Next-Generation Antibody for AML
Swiss Researchers get to the Genetic Bottom of Kidney Cancer
FDA Fast Tracks Muscular Dystrophy Drug backed by Woodford
Labiotech UG, All Rights Reserved -
Send this to friend